Chief Development Officer of Trillium Therapeutics Inc. (NASDAQ:TRIL), Petrova Penka, sells 508 shares worth $7,200
According to Trillium Therapeutics Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 10 07:18 PM, company Chief Development Officer, Petrova Penka disclosed selling 508 shares at a cost of $14.17. At the time of this transaction (Feb 09), this trade was worth $7,200 in total. As of Feb 09, Petrova Penka now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Trillium Therapeutics Inc. (NASDAQ:TRIL) Chief Development Officer, Petrova Penka, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 5,312 shares at the rate of $12.65 per share. Total worth of this trade was $67,197. Total number of shares owned as of Feb 08 were 0
- SEC Form 4 filing: Jan 08: Sold 2,604 shares at the rate of $15.50 per share. Total worth of this trade was $40,365. Total number of shares owned as of Jan 08 were 0
- SEC Form 4 filing: Jan 07: Sold 2,708 shares at the rate of $14.71 per share. Total worth of this trade was $39,843. Total number of shares owned as of Jan 07 were 0
Posted by
George Daniels
on Wednesday February 10 2021, 10:37 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
